Vicore Pharma to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

About this update from Vicore Pharma Holding Ab

[{"type":"text","content":"STOCKHOLM, SE / ACCESS Newswire / February 18, 2026 / Vicore Pharma Holding AB (Nasdaq Stockholm:VICO)(STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs), today announced that the company will present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference:","length":328,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Location: Virtual","length":17,"tagName":"p"}]},{"val":[{"type":"text","content":"Format: Presentation and 1×1 meetings","length":37,"tagName":"p"}]},{"val":[{"type":"text","content":"Presentation Date and Time: Wednesday, February 25 at 4:00 PM EST","length":65,"tagName":"p"}]},{"val":[{"type":"text","content":"Webcast: Link","length":13,"tagName":"p"}]},{"val":[{"type":"text","content":"Participants: Ahmed Mousa, CEO, and Megan Richards, VP of IR and Comms","length":70,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":202,"olType":false},{"type":"text","content":"For more information, please contact:Megan Richards, VP of IR and Comms, +1 978 269-4372, [email protected] Jeppsson, CFO, +46 70 553 14 65, [email protected]","length":191,"tagName":"p"},{"type":"text","content":"About Vicore Pharma Vicore Pharma is a clinical-stage biopharmaceutical company unlocking the potential of a new class of drugs with disease-modifying potential in respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). The company's lead program, buloxibutid, is a first-in-class oral small molecule angiotensin II type 2 receptor agonist, which has received Orphan Drug and Fast Track designation from the United States Food and Drug Administration and is currently being investigated in the global 52-week Phase 2b ASPIRE trial in IPF.","length":569,"tagName":"p"},{"type":"text","content":"Vicore is publicly listed on the Nasdaq Stockholm exchange with the ticker VICO. www.vicorepharma.com","length":101,"tagName":"p"},{"type":"text","content":"AttachmentsVicore Pharma to present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference","length":103,"tagName":"p"},{"type":"text","content":"SOURCE: Vicore Pharma Holding","length":29,"tagName":"p"},{"type":"text","content":"View the original press release on ACCESS Newswire","length":50,"tagName":"p"}]

More updates from Vicore Pharma Holding Ab